Health

Results: 4909-4920 of 8221

PR Newswire associated0

Lexogen launches LUTHOR HD Pool and a dedicated LUTHOR single cell dispenser: Expanding High-Throughput Single-cell RNA Sequencing Solutions

PR Newswire associated0

Piramal Pharma's GHG Commitment Validated and Approved by SBTi

Buyback of Class B shares in Essity during week 37, 2024

Corza Medical Appoints Jason Abair as Vice President of Legal & Chief Compliance Officer

Debiopharm & WhiteLab Genomics Announce a Strategic Partnership to Advance Drug Target and Design in Oncology

PR Newswire associated0

PhytoHealth Corporation announced a new clinical study results published at 2024 ESMO Congress: PG2 plus preoperative chemoradiotherapy improves survival in patients with locally advanced esophageal cancer

PR Newswire associated0

Remedee Labs' Solution becomes the first CE marked medical device (class IIa) approved for the treatment of fibromyalgia in Europe

PR Newswire associated0

Luohu Explores Economic Opportunities in Europe, Strengthens Ties with Portugal

Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer

Incyte’s Retifanlimab (Zynyz®) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium

PR Newswire associated0

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

PR Newswire associated0

Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)